Original Article

Journal of Cerebral Blood Flow & Metabolism (2005) 25, 1183–1196. doi:10.1038/sj.jcbfm.9600113; published online 30 March 2005

Cerebral metabolic response to low blood flow: possible role of cytochrome oxidase inhibition

The study was supported by the Aarhus University Research Foundation, the NOVO Nordic Foundation, the Danish Medical Association's Research Foundation, MRC (Denmark) Grants 9305246, 9305427, and 9601888, and the National Science Foundation of Denmark center-of-excellence grant to the Center of Functionally Integrative Neuroscience at the University of Aarhus.

Albert Gjedde1,4, Peter Johannsen1, Georg E Cold2 and Leif Østergaard3,4

  1. 1Pathophysiology and Experimental Tomography Center, Aarhus University Hospital in Aarhus, Aarhus, Denmark
  2. 2Department of Anesthesiology, Division of Neuroanesthesiology, Aarhus University Hospital in Aarhus, Aarhus, Denmark
  3. 3Department of Neuroradiology, Aarhus University Hospital in Aarhus, Aarhus, Denmark
  4. 4Center of Functionally Integrative Neuroscience, Aarhus University, Aarhus, Denmark

Correspondence: A Gjedde, PET/CFIN, Aarhus University Hospital in Aarhus 44, Norrebrogade, Aarhus 8000, Denmark. E-mail: albert@pet.auh.dk

Received 28 August 2004; Revised 10 September 2004; Accepted 21 October 2004; Published online 30 March 2005.

Top

Abstract

The reactions of cerebral metabolism to imposed changes of cerebral blood flow (CBF) are poorly understood. A common explanation of the mismatched CBF and oxygen consumption (CMRO2) during neuronal excitation holds that blood flow rises more than oxygen consumption to compensate for an absent oxygen reserve in brain mitochondria. The claim conversely implies that oxygen consumption must decline when blood flow declines. As the prevailing rate of reaction of oxygen with cytochrome c oxidase is linked to the tension of oxygen, the claim fails to explain how oxygen consumption is maintained during moderate reductions of CBF imposed by hyperventilation (hypocapnia) or cyclooxygenase (COX) inhibition. To resolve this contradiction, we extended the previously published oxygen delivery model with a term allowing for the adjustment of the affinity of cytochrome c oxidase to a prevailing oxygen tension. The extended model predicted constant oxygen consumption at moderately reduced blood flow. We determined the change of affinity of cytochrome c oxidase in the extended model by measuring CBF in seven, and CMRO2 in five, young healthy volunteers before and during COX inhbition with indomethacin. The average CBF declined 35%, while neither regional nor average CMRO2 changed significantly. The adjustment of cytochrome c oxidase affinity to the declining oxygen delivery could be ascribed to a hypothetical factor with several properties in common with nitric oxide.

Keywords:

CBF, CMRO2, humans, indomethacin, PET

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

Extra navigation

.

naturejobs

ADVERTISEMENT